Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001137050-15-000010
Filing Date
2015-01-12
Accepted
2015-01-12 11:52:42
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 form10ksept2014v8bclean.htm 10-K 948262
2 form10ksept2014v8bclean001.jpg GRAPHIC 34664
3 form10ksept2014v8bclean002.jpg GRAPHIC 55666
4 form10ksept2014v8bclean003.jpg GRAPHIC 36637
5 exh311.htm EX-31 5619
6 exh312.htm EX-31 5608
7 exh321.htm EX-32 2078
8 exh322.htm EX-32 1963
  Complete submission text file 0001137050-15-000010.txt   3790383

Data Files

Seq Description Document Type Size
9 peak-20140930.xml EX-101.INS 424376
10 peak-20140930.xsd EX-101.SCH 27679
11 peak-20140930_lab.xml EX-101.LAB 145443
12 peak-20140930_pre.xml EX-101.PRE 142363
13 peak-20140930_cal.xml EX-101.CAL 9084
14 peak-20140930_def.xml EX-101.DEF 66438
Mailing Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303
Business Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303 303-415-2557
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-53855 | Film No.: 15521141
SIC: 2834 Pharmaceutical Preparations